HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Kohl’s stock has gone bonkers, and meme stocks look to be back in fashion. There’s a laundry list of candidates to join the party.

Coca‑Cola has announced that it will launch a new version of its iconic Coke in the U.S. this autumn, sweetened with ...

XOOX is turning backpacks into portable entertainment hubs, while CyFireAI helps small businesses stay ahead of cyber threats ...

The BUZZ Index returned 12.68% during the month of June compared to a return of 5.09% for the S&P 500 Index during the same ...

NIKE Inc.’s NKE ongoing efforts to streamline inventory and reset the marketplace remain central to its turnaround strategy.

Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT).

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

The Zacks Consensus Estimate for the June-quarter earnings is pegged at $1.56 per share, implying a 12.9% decrease from the ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the ...